Across TCGA pan-cancer cohorts, MUC6 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated MUC6 data layer compared with 25 for mass-spec protein and 8 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher MUC6 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated MUC6 expression acts as an unfavorable survival marker.

LUAD and LSCC are the cancer types where MUC6 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Quartile	II,III,IV	0.396	0.892	.013	7	view →
LSCC	OS	Quartile	All	0.582	1.000	.024	2	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: MUC6 tumor-vs-normal RNA expression · all MUC6 data types